NovaBridge Biosciences (NBP) Short-term Investments (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Short-term Investments data on file, last reported at $210000.0 in Q4 2025.

• Short-term Investments for Q4 2025 came in at $210000.0, down 99.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $210000.0 (down 99.8% YoY), and the FY2025 annual result was $210000.0, down 99.8% from the prior year.
• Short-term Investments was little changed at $210000.0 in Q4 2025 per NBP's latest filing, from $210000.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $117.8 billion in Q4 2021 and troughed at $210000.0 in Q2 2025.
• A 5-year average of $9.1 billion and a median of $55.5 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2021 and 2022: Short-term Investments jumped 2475947.76% in 2021, then tumbled 99.99% in 2022.
• A 5-year view of Short-term Investments shows it stood at $117.8 billion in 2021, then plunged by 99.99% to $13.6 million in 2022, then surged by 46.2% to $19.9 million in 2023, then soared by 428.54% to $105.1 million in 2024, then slumped by 99.8% to $210000.0 in 2025.
• Business Quant data shows NBP's Short-term Investments at $210000.0 in Q4 2025, $210000.0 in Q3 2025, and $210000.0 in Q2 2025.